Novo Growth
Overview
Novo Growth is a venture capital firm specializing in investments within the healthcare sector, with a particular emphasis on digital health and biotechnology. The firm is part of Novo Holdings A/S, a global life sciences investor based in Denmark, and operates in various regions, including the United States, Denmark, China, Singapore, and the United Kingdom. The firm's investment strategy encompasses a wide range of stages, from seed and early-stage investments to growth and pre-IPO funding. Novo Growth focuses on sectors such as healthcare, biotechnology, digital health, and life sciences, aiming to support innovative companies that have the potential to transform these industries. With a global presence and a commitment to advancing healthcare through strategic investments, Novo Growth leverages its extensive network and expertise to drive value creation and foster innovation in the healthcare sector.
Investment Focus
- Innovative healthcare solutions
- Strong management teams
- Scalable business models
- Potential for significant impact in the healthcare sector
Reach Novo Growth directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Novo Growth
What sectors does Novo Growth invest in?
Novo Growth invests in Healthcare, Life Sciences, Digital Health and Biotechnology, and is based in Massachusetts, United States. Novo Growth is listed as a venture capital in the ConnectSafely investor database.
What stage does Novo Growth invest at?
Novo Growth backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage.
Which regions does Novo Growth invest in?
Novo Growth invests across United States, United Kingdom, Singapore, China and Denmark.
Last updated · Source: ConnectSafely investor database
